Anti-Aurora A抗体[35C1]
参阅全部 Aurora A 一抗
小鼠单克隆抗体[35C1] to Aurora A
Mouse
适用于: Flow Cyt (Intra), WB, ICC/IFmore details
与反应: Human
预测可用于: Mouse
Recombinant full length protein corresponding to Human Aurora A.
Human HeLa and mouse M-ICc12 cell lysates for Western blotting and human 293 or mouse LLC1 cell lines for IF. Flow Cyt (Intra): HeLa cells. ICC: HeLa cells
This antibody clone is manufactured by Abcam. If you require a custom buffer formulation or conjugation for your experiments, please contact orders@abcam.com.
The Life Science industry has been in the grips of a reproducibility crisis for a number of years. Abcam is leading the way in addressing this with our range of recombinant monoclonal antibodies and knockout edited cell lines for gold-standard validation. Please check that this product meets your needs before purchasing.
If you have any questions, special requirements or concerns, please send us an inquiry and/or contact our Support team ahead of purchase. Recommended alternatives for this product can be found below, along with publications, customer reviews and Q&As
Liquid
Shipped at 4°C. Store at +4°C short term (1-2 weeks). Upon delivery aliquot. Store at -20°C or -80°C. Avoid freeze / thaw cycle.
pH: 7.40
Preservative: 0.09% Sodium azide
Constituent: PBS
浓度
100 µg 浓度为 1 mg/ml
Affinity purified
单克隆
35C1
Sp2/0-Ag14
IgG2b
Abpromise™承诺保证使用ab13824于以下的经测试应用
“应用说明”部分 下显示的仅为推荐的起始稀释度;实际最佳的稀释度/浓度应由使用者检定。
应用 | Ab评论 | 说明 |
---|---|---|
Flow Cyt (Intra) | Use 2µg for 106 cells. ab170192 - Mouse monoclonal IgG2b, is suitable for use as an isotype control with this antibody. | |
WB | (5) | Use a concentration of 1 µg/ml. Detects a band of approximately 46 kDa. |
ICC/IF | (1) | Use a concentration of 5 µg/ml. |
Entrez Gene: 6790 Human
Entrez Gene: 20878 Mouse
Omim: 603072 Human
SwissProt: O14965 Human
SwissProt: P97477 Mouse
Unigene: 250822 Human
Unigene: 249363 Mouse
AURA antibody
Aurka antibody
Aurora 2 antibody
Aurora A antibody
Aurora kinase A antibody
Aurora-related kinase 1 antibody
Aurora/IPL1 like kinase antibody
AURORA/IPL1-like kinase antibody
Aurora/IPL1-related kinase 1 antibody
AURORA2 antibody
Breast tumor-amplified kinase antibody
BTAK antibody
hARK1 antibody
IAK antibody
IPL1 related kinase antibody
MGC34538 antibody
OTTHUMP00000031340 antibody
OTTHUMP00000031341 antibody
OTTHUMP00000031342 antibody
OTTHUMP00000031343 antibody
OTTHUMP00000031344 antibody
OTTHUMP00000031345 antibody
OTTHUMP00000166071 antibody
OTTHUMP00000166072 antibody
PPP1R47 antibody
Protein phosphatase 1, regulatory subunit 47 antibody
Serine/threonine kinase 15 antibody
Serine/threonine kinase 6 antibody
Serine/threonine protein kinase 15 antibody
Serine/threonine-protein kinase 15 antibody
Serine/threonine-protein kinase 6 antibody
Serine/threonine-protein kinase aurora-A antibody
STK15 antibody
STK6 antibody
STK6_HUMAN antibody
STK7 antibody
AIK antibody
ARK-1 antibody
ARK1 antibody
Western blot - Anti-Aurora A antibody [35C1] (ab13824)
All lanes : Anti-Aurora A antibody [35C1] (ab13824) at 5 µg/ml
Lane 1 : Jurkat (Human T cell lymphoblast-like cell line) Whole Cell Lysate
Lane 2 : HEK293 (Human embryonic kidney cell line) Whole Cell Lysate
Lysates/proteins at 20 µg per lane.
Secondary
All lanes : Goat polyclonal to Mouse IgG - H&L - Pre-Adsorbed (HRP) at 1/3000 dilution
Developed using the ECL technique.
Performed under reducing conditions.
Predicted band size: 46 kDa
Observed band size: 50 kDawhy is the actual band size different from the predicted?
Additional bands at: 125 kDa (possible non-specific binding), 55 kDa (possible non-specific binding)
Exposure time: 20 minutes
This blot was produced using 4-12% Bis-tris gel under the MOPS buffer system. The gel was run at 200v for 50 minutes. The membrane was then blocked for an hour using 2% Bovine Serum Albumin before being incubated with ab13824 over night at 4°C. Antibody binding was detected using an anti-mouse antibody conjugated to HRP, and visualised using ECL development solution.
Immunocytochemistry/ Immunofluorescence - Anti-Aurora A antibody [35C1] (ab13824)
This data was developed using the same antibody clone in a different buffer formulation without PBS and sodium azide (ab264552)
ab264552 staining Aurora A in HeLa cells. The cells were fixed with 100% methanol (5 min), permeabilized with 0.1% PBS-Triton X-100 for 5 minutes and then blocked with 1% BSA/10% normal goat serum/0.3M glycine in 0.1% PBS-Tween for 1h. The cells were then incubated overnight at 4°C with ab264552 at 5µg/ml and ab6046, Rabbit polyclonal to beta Tubulin - Loading Control. Cells were then incubated with ab150117, Goat polyclonal Secondary Antibody to Mouse IgG H&L (Alexa Fluor® 488) preadsorbed at 1/1000 dilution (shown in green) and ab150080, Goat polyclonal Secondary Antibody to Rabbit IgG - H&L (Alexa Fluor® 594) at 1/1000 dilution (shown in pseudocolour red). Nuclear DNA was labelled with DAPI (shown in blue).
Image was acquired with a confocal microscope (Leica-Microsystems TCS SP8) and a single confocal section is shown.
Immunocytochemistry/ Immunofluorescence - Anti-Aurora A antibody [35C1] (ab13824)This image is courtesy of an Abreview submitted by Dr Kirk McManus
ab13824, at 1/2000 dilution, detecting Aurora A (green) in Hela Cells in conjunction with a Goat anti-mouse secondary antibody conjugated to Cy3®. Cells were fixed with methanol and counterstained with DAPI. Please refer to abreview for further details.
Flow Cytometry (Intracellular) - Anti-Aurora A antibody [35C1] (ab13824)
Overlay histogram showing HeLa cells stained with ab13824 (red line). The cells were fixed with 80% methanol (5 min) and then permeabilized with 0.1% PBS-Tween for 20 min. The cells were then incubated in 1x PBS / 10% normal goat serum / 0.3M glycine to block non-specific protein-protein interactions. The cells were then incubated with the antibody (ab13824, 2µg/1x106 cells) for 30 min at 22ºC. The secondary antibody used was DyLight® 488 goat anti-mouse IgG (H+L) (ab96879) at 1/500 dilution for 30 min at 22ºC. Isotype control antibody (black line) was mouse IgG2b [PLPV219] (ab91366, 2µg/1x106 cells ) used under the same conditions. Acquisition of >5,000 events was performed.